Darby John Patrick 4
4 · Encompass Health Corp · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
Encompass Health (EHC) EVP Darby J. Patrick Receives Award
What Happened
- Darby John Patrick, EVP, General Counsel & Secretary of Encompass Health (EHC), received a derivative equity award of 5,967 shares on 2026-03-02 valued at approximately $644,794 (5,967 x $108.06). Separately, 416 shares were disposed on 2026-02-28 to satisfy tax withholding obligations, totaling about $44,878 (416 x $107.88). The award is an acquisition (derivative) rather than an open-market purchase.
Key Details
- Transaction dates and amounts:
- 2026-02-28: 416 shares withheld/disposed to cover taxes at $107.88 — $44,878 (footnote F1: withheld for tax withholding on vesting).
- 2026-03-02: Grant/acquisition of 5,967 derivative shares at $108.06 — $644,794 (footnote F2: option becomes exercisable in equal annual installments over a three-year period commencing March 2, 2027).
- Shares owned after the transactions: Not specified in the provided filing.
- Filing: Form 4 filed 2026-03-03 covering the 2/28 and 3/2 transactions; the filing does not indicate a late/untimely submission.
- Transaction codes: A = award/grant (derivative); F = tax withholding (shares surrendered/withheld).
Context
- The 5,967-share entry is a company grant/derivative award (likely options or restricted stock units) rather than an open-market buy — it signals compensation/retention, not a market purchase.
- The 416-share disposition was a routine tax-withholding event related to vesting, not a discretionary sale.
Insider Transaction Report
Form 4
Darby John Patrick
EVP, Gen Counsel & Secretary
Transactions
- Tax Payment
Encompass Health Common Stock
[F1]2026-02-28$107.88/sh−416$44,878→ 83,947 total - Award
Non-qualified Stock Option (Right to Buy)
[F2]2026-03-02$108.06/sh+5,967$644,794→ 5,967 totalExercise: $108.06From: 2027-03-02Exp: 2036-03-02→ Encompass Health Common Stock (5,967 underlying)
Footnotes (2)
- [F1]These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.
- [F2]The option becomes exercisable in equal annual installments over a three-year period commencing March 2, 2027.
Signature
Patrick Darby|2026-03-03